Edward Michael – Startup Investor Profile

Edward Michael, Managing Partner at LionBird, focuses on early-stage technology startups in healthcare, commerce, and enterprise. The investment check size ranges from $200K to $1.5M. Edward Michael has a professional background of 25 years at Abbott Laboratories, serving as Executive Vice President of Diagnostic Products. Specific previous investments are not available. LionBird’s partnership and collaboration styles involve digital health-focused activities. For more details, visit LionBird’s website at https://www.lionbird.com/

Location: Evanston, Illinois

Country: United States of America

Investment Regions:

Investment Stages: pre-seed, seed

Website: https://www.lionbird.com/

AI Reasoning: I found a press release showing Ed (Edward) Michael was involved as Managing Partner/board observer in Phantom Neuro’s seed on March 25, 2022, and news showing Phantom Neuro raised a $19M Series A on April 15, 2025 (which lists investors including Ottobock leading the round). LionBird had involvement earlier and Ed Michael was associated; EasyVC reported Ed Michael’s last known investment was Phantom Neuro on April 15, 2025. Given the April 15, 2025 investment is within 6 months from the reference date, the correct classification is the highest activity band.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.